Classic Induction — Competitive Intelligence Brief

Classic Induction (Classic Induction) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anesthetic. Area: Anesthesiology.

marketed Anesthetic Anesthesiology Small molecule

Target snapshot

Classic Induction (Classic Induction) — The University of Texas Health Science Center, Houston. Classic induction is a type of anesthesia that induces a state of unconsciousness.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Classic Induction TARGET	Classic Induction	The University of Texas Health Science Center, Houston	marketed	Anesthetic
Tetracaine Hydrochloride	TETRACAINE	Alcon Labs	marketed	Ester Local Anesthetic	Sodium channel protein type 7 subunit alpha	2005-01-01
Septocaine	ARTICAINE		marketed	Amide Local Anesthetic	Sodium channel alpha subunits; brain (Types I, II, III)	2000-01-01
Naropin	ROPIVACAINE	Fresenius Kabi	marketed	Amide Local Anesthetic	Sodium channel protein type 5 subunit alpha	1996-01-01
SEVOFLURANE	SEVOFLURANE		marketed	General Anesthetic [EPC]		1995-01-01
Suprane	DESFLURANE	Baxter	marketed	General Anesthetic [EPC]	GABA-A receptor; anion channel	1992-01-01
PROPOFOL	PROPOFOL		marketed	General Anesthetic [EPC]		1989-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anesthetic class)

1. Express Specialty Pharmacy · 1 drug in this class
2. Nantes University Hospital · 1 drug in this class
3. The University of Texas Health Science Center, Houston · 1 drug in this class
4. Universidad de Colima · 1 drug in this class
5. University Hospital, Montpellier · 1 drug in this class